Annual report pursuant to Section 13 and 15(d)

Licensing and Other Arrangements - Janssen (Details)

v3.24.0.1
Licensing and Other Arrangements - Janssen (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 31, 2019
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2019
Licensing and other arrangements        
Revenue from contracts with customers   $ 2,650 $ 4,150  
Janssen | License Agreement        
Licensing and other arrangements        
Cash payment received $ 2,500      
Maximum eligible milestone payments receivable per discovery product candidate $ 3,000      
Percentage of royalty on worldwide net sales of each product upon commercialization 0.75%      
Revenue from contracts with customers   1,500 0 $ 2,500
Contract assets   0 0  
Contract liabilities   0 0  
Capitalized contract costs   $ 0 $ 0